Naegleria fowleri was causative agent of primary amoebic meningoencephalitis (PAM). Accroding to the failure of treatment, several researches reported the activity of chemotherapeutic drugs against N. fowleri but we did not know the drug resistance of the amoebae. The purpose of this study was to examine the effects of drugs ( 
INTRODUCTION
Naegleria fowleri causes severe meningoencephalitis mainly in children and young adults. Due to the treatments have not been succeeded, most of patients die from N. fowleri infection [1] . The effect of drug against N. fowleri has been carried out both in vitro and in vivo studies which provided for clinical trends for treatment [2] . A prelude of drug resistant has been frequently documented in recent years [3] . Several researches on antifungal resistant have been focused on elucidating the molecular basis and transcriptional regulation of azole in Candida spp. [4] . The resistance to azole uptake of C. albicans can be achieved with the introduction of key point mutation in and/or up regulation of gene expression which encodes on efflux pump; EGR11, MDR including ATP-binding cassette transporter molecules CDR2 [5] . In addition, antifungal resistant was involved sterol uptake which was controled by UPC2 gene [6] . Owing to failure treatment of PAM, one of the major problems was drug resistant from gene alteration. Up to date, a study has been addressed the intrinsic resistant on nfa1 and Mp2Cl5 genes which regulated pathogenesis of the amoebae. The results demonstrated that either nfa1 resistant to fluconazole or Mp2Cl5 resistant to amphotericin B, azithromycin and artesunate of N. fowleri were found [7] . Owing to the dominant ITS, located in the 5.8S rRNA gene and species-specific chromosomal DNA pB2.3 genes were used for identify pathogenic N. fowleri [8] and diversity of N. fowleri at molecular level [9] , we investigated the activity of drugs on ITS and pB2.3 genes of N. fowleri. This report revealed the ability of Naegleria genes against drugs of choice.
MATERIALS AND METHODS

Naegleria Fowleri Cultivation
Free living N. fowleri trophozoites (Khon-Kaen strain) were cultured in Nelson's medium supplemented with 5% heat-inactivated fetal calf serum (FCS) without antibiotics at 37˚C. Trophozoites were tested with the concentration of amphortericin B, voriconazole, fluconazole, chlorpromazine, artesunate, azithromycin and gentamicin at IC 50 [10] during 15 -120 min, triplicate. Untreated trophozoite was used for negative control. At indicated times, trophozoites were twice washed with normal saline and frozen at -80˚C until required.
RNA Extraction
Total RNA was extracted from untreated or treated amoebae trophozoites using Tri Reagent (Sigma-Aldrich, USA). For positive control, nf actin gene (housekeeping gene) of N.fowleri was confirmed by primer 5′-ACT CTG GTG ATG GTG TCT CTC ACA C-3′ and 5′-CTC TGA CAA TTT CTC TCT CAG TGG-3′. The amplicons of amoebae were prepared from primers of ITS (ITS1; 5′-GAACCTGCGTAGGGATCATTT-3′ and ITS2; 5′-TTTCTTTTCCTCCC CTTATTA-3′) and pB2.3 (p3f; 5′-GTGAAAACCTTTTTTCCATTTACA-3′) and p3r; 5′-AAATAAAAA TTACCATTTGAAA-3′) by one -step Super-script PCR (Invitrogen, Gransland). MW of each amplicon was detected by 1.5% Agarose Gel Electrophoresis at 100 V for 30 min.
RESULTS AND DISCUSSION
In our studies we demonstrated the responsibility of N. fowleri to the effects of drugs (amphotericin B, artesunate, azithromycin, voriconazole, chlorpromazine, fluconazole and gentamicin sulphate) on ITS and of pB2.3 gene by RT-PCR. The number of N. fowleri treated or untreated N. fowleri was not significant different between two groups at time intervals (the results was not shown) (t < 0.005). Total RNA was extracted from this two groups using Tri Reagent (Sigma-Aldrich, USA) at indicated time. As a positive control, we used nf actin to amplify under the same RT-PCR condition and regulation of expression of nf actin gene was detected at 170 bp at 15 -120 min. The up regulate of nf actin was compared with treated or untreated amoebae at every point of time. We found that untreated N.fowleri showed up regulate of ITS gene at 450 while ITS gene expression from treated trophozoites with voriconazole, fluconazole or chlorpromazine was not observed during 120 min. In contrast, trophozoites treated with amphotericin B was found at least 30 min whereas trophozoites treated with azithromycin or gentamicin was shown at least 45 min (Figure 1 ). Similarly, we tested the drugs activity against pB2.3 gene expression of amoebae trophozoites. The untreated trophozoites showed bright band fragment at 310 bp as shown in Figure 2 . Interesting, we did not observe pB2.3 gene expression from treated trophozoites with a panel of drugs at 120 min, except artesunate. It is possibly suggested that ITS gene of N. fowleri trophozoite was resisted to amphotericin B, azithromycin or gentamicin including the pB2.3 gene was resisted to artesunate. Amphotericin B has been generally recognized for fungal and protozoa treatment, many publications reported amphotericin B-resistant genes in Candida lusitaniae, Saccharomyces cerevisiae [11] and Cryptococcus neoformans [12] . However, it has been reported in pathogenic protozoa; Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis and also occurred anaerobic protozoa; Blastocystis hominis, Cryptosporidium parvum, Isospora spp., Cyclosporssporidia spp. [13] . In addition, amphotericin B resistant gene was also found in vector born protozoa, Leishmania tarentolae [14] .
The mechanism of amphotericin B, polyene resistant of C. albicans and S. cerevisiae caused by mutation of EGR genes which control the production of ergosterol and sensitivity to polyenes. As the result of EGR6 mutant strain of C. lusitaniae transcription, the reduced ergosterol content was appeared [15] . A study of EGR6 mutant caused unable to form amphotericin B-generated pores in the cell membrane on Candida spp [16] . Our study revealed amphotericin B resistant ITS gene of N. fowleri was firstly appeared. Moreover, drug resistant; azithromycin, gentamicin sulphate to ITS and artesunate to pB2.3 of N. fowleri were also demonstrated. A few publications reported the azithromycin resistant in Pseudomonas aeruginosa [17] and genetic mutation at 23S rRNA region of Ureaplasma urealyticum and Neisseria gonorrhoeae [18] . Gene resistant, ermG , to azithromycin was established in Bacteroides. Mechanism of azithromycin resistant established at MexCD-OprJ pump of Pseudomonas aeruginosa biofims [19] .
Gentamicin has been general used in cultivation; Enterococcus faecali [20] , Pseudomonas aeruginosa [21] . The occurrence of gentamicin-resistant genes of gram negative bacteria; Enterobacteriaceae, Pseudomonas, Acinetobacter were isoloated from different environment mainly originating from sewage, faces, coastal water
